Global Terbinafine (Lamisil) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Terbinafine is also known as Terbinafine hydrochloride (Lamisil).It is a synthetic allylamine antifungal.It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.
LPI (LP Information)' newest research report, the “Terbinafine (Lamisil) Industry Forecast” looks at past sales and reviews total world Terbinafine (Lamisil) sales in 2022, providing a comprehensive analysis by region and market sector of projected Terbinafine (Lamisil) sales for 2023 through 2029. With Terbinafine (Lamisil) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Terbinafine (Lamisil) industry.
This Insight Report provides a comprehensive analysis of the global Terbinafine (Lamisil) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Terbinafine (Lamisil) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Terbinafine (Lamisil) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Terbinafine (Lamisil) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Terbinafine (Lamisil).
The global Terbinafine (Lamisil) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Terbinafine (Lamisil) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Terbinafine (Lamisil) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Terbinafine (Lamisil) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Terbinafine (Lamisil) players cover Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation and Auro Pharma Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Terbinafine (Lamisil) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Terbinafine (Lamisil) market?
What factors are driving Terbinafine (Lamisil) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Terbinafine (Lamisil) market opportunities vary by end market size?
How does Terbinafine (Lamisil) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Terbinafine is also known as Terbinafine hydrochloride (Lamisil).It is a synthetic allylamine antifungal.It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.
LPI (LP Information)' newest research report, the “Terbinafine (Lamisil) Industry Forecast” looks at past sales and reviews total world Terbinafine (Lamisil) sales in 2022, providing a comprehensive analysis by region and market sector of projected Terbinafine (Lamisil) sales for 2023 through 2029. With Terbinafine (Lamisil) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Terbinafine (Lamisil) industry.
This Insight Report provides a comprehensive analysis of the global Terbinafine (Lamisil) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Terbinafine (Lamisil) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Terbinafine (Lamisil) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Terbinafine (Lamisil) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Terbinafine (Lamisil).
The global Terbinafine (Lamisil) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Terbinafine (Lamisil) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Terbinafine (Lamisil) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Terbinafine (Lamisil) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Terbinafine (Lamisil) players cover Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation and Auro Pharma Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Terbinafine (Lamisil) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- External Use
- Fungal Infection Of The Skin And Mucous Membrane
- Onychomycosis
- Bronchial Asthma
- Gynecological Anti-Infection Preparation
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Perrigo
- Novartis Pharmaceuticals Corporation
- Gokul Pharma
- TEVA
- Mylan Pharmaceuticals
- Pfizer
- Sivem Pharmaceuticals
- Apotex Corporation
- Auro Pharma Inc
- PLIVA
- Jamp Pharma Corporation
- Nu Pharm
- Codal Synto
- Qd Pharmaceuticals
- Pharmel Inc
- Smaart Pharmaceutticals
- Qilu Pharmaceutical
- Qingdao Jinfeng Pharmaceutical
What is the 10-year outlook for the global Terbinafine (Lamisil) market?
What factors are driving Terbinafine (Lamisil) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Terbinafine (Lamisil) market opportunities vary by end market size?
How does Terbinafine (Lamisil) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Terbinafine (Lamisil) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Terbinafine (Lamisil) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Terbinafine (Lamisil) by Country/Region, 2018, 2022 & 2029
2.2 Terbinafine (Lamisil) Segment by Type
2.2.1 Oral
2.2.2 External Use
2.3 Terbinafine (Lamisil) Sales by Type
2.3.1 Global Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
2.3.2 Global Terbinafine (Lamisil) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Terbinafine (Lamisil) Sale Price by Type (2018-2023)
2.4 Terbinafine (Lamisil) Segment by Application
2.4.1 Fungal Infection Of The Skin And Mucous Membrane
2.4.2 Onychomycosis
2.4.3 Bronchial Asthma
2.4.4 Gynecological Anti-Infection Preparation
2.4.5 Other
2.5 Terbinafine (Lamisil) Sales by Application
2.5.1 Global Terbinafine (Lamisil) Sale Market Share by Application (2018-2023)
2.5.2 Global Terbinafine (Lamisil) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Terbinafine (Lamisil) Sale Price by Application (2018-2023)
3 GLOBAL TERBINAFINE (LAMISIL) BY COMPANY
3.1 Global Terbinafine (Lamisil) Breakdown Data by Company
3.1.1 Global Terbinafine (Lamisil) Annual Sales by Company (2018-2023)
3.1.2 Global Terbinafine (Lamisil) Sales Market Share by Company (2018-2023)
3.2 Global Terbinafine (Lamisil) Annual Revenue by Company (2018-2023)
3.2.1 Global Terbinafine (Lamisil) Revenue by Company (2018-2023)
3.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Company (2018-2023)
3.3 Global Terbinafine (Lamisil) Sale Price by Company
3.4 Key Manufacturers Terbinafine (Lamisil) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Terbinafine (Lamisil) Product Location Distribution
3.4.2 Players Terbinafine (Lamisil) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TERBINAFINE (LAMISIL) BY GEOGRAPHIC REGION
4.1 World Historic Terbinafine (Lamisil) Market Size by Geographic Region (2018-2023)
4.1.1 Global Terbinafine (Lamisil) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Terbinafine (Lamisil) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Terbinafine (Lamisil) Market Size by Country/Region (2018-2023)
4.2.1 Global Terbinafine (Lamisil) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Terbinafine (Lamisil) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Terbinafine (Lamisil) Sales Growth
4.4 APAC Terbinafine (Lamisil) Sales Growth
4.5 Europe Terbinafine (Lamisil) Sales Growth
4.6 Middle East & Africa Terbinafine (Lamisil) Sales Growth
5 AMERICAS
5.1 Americas Terbinafine (Lamisil) Sales by Country
5.1.1 Americas Terbinafine (Lamisil) Sales by Country (2018-2023)
5.1.2 Americas Terbinafine (Lamisil) Revenue by Country (2018-2023)
5.2 Americas Terbinafine (Lamisil) Sales by Type
5.3 Americas Terbinafine (Lamisil) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Terbinafine (Lamisil) Sales by Region
6.1.1 APAC Terbinafine (Lamisil) Sales by Region (2018-2023)
6.1.2 APAC Terbinafine (Lamisil) Revenue by Region (2018-2023)
6.2 APAC Terbinafine (Lamisil) Sales by Type
6.3 APAC Terbinafine (Lamisil) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Terbinafine (Lamisil) by Country
7.1.1 Europe Terbinafine (Lamisil) Sales by Country (2018-2023)
7.1.2 Europe Terbinafine (Lamisil) Revenue by Country (2018-2023)
7.2 Europe Terbinafine (Lamisil) Sales by Type
7.3 Europe Terbinafine (Lamisil) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Terbinafine (Lamisil) by Country
8.1.1 Middle East & Africa Terbinafine (Lamisil) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2018-2023)
8.2 Middle East & Africa Terbinafine (Lamisil) Sales by Type
8.3 Middle East & Africa Terbinafine (Lamisil) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Terbinafine (Lamisil)
10.3 Manufacturing Process Analysis of Terbinafine (Lamisil)
10.4 Industry Chain Structure of Terbinafine (Lamisil)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Terbinafine (Lamisil) Distributors
11.3 Terbinafine (Lamisil) Customer
12 WORLD FORECAST REVIEW FOR TERBINAFINE (LAMISIL) BY GEOGRAPHIC REGION
12.1 Global Terbinafine (Lamisil) Market Size Forecast by Region
12.1.1 Global Terbinafine (Lamisil) Forecast by Region (2024-2029)
12.1.2 Global Terbinafine (Lamisil) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Terbinafine (Lamisil) Forecast by Type
12.7 Global Terbinafine (Lamisil) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Perrigo
13.1.1 Perrigo Company Information
13.1.2 Perrigo Terbinafine (Lamisil) Product Portfolios and Specifications
13.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Perrigo Main Business Overview
13.1.5 Perrigo Latest Developments
13.2 Novartis Pharmaceuticals Corporation
13.2.1 Novartis Pharmaceuticals Corporation Company Information
13.2.2 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
13.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Pharmaceuticals Corporation Main Business Overview
13.2.5 Novartis Pharmaceuticals Corporation Latest Developments
13.3 Gokul Pharma
13.3.1 Gokul Pharma Company Information
13.3.2 Gokul Pharma Terbinafine (Lamisil) Product Portfolios and Specifications
13.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Gokul Pharma Main Business Overview
13.3.5 Gokul Pharma Latest Developments
13.4 TEVA
13.4.1 TEVA Company Information
13.4.2 TEVA Terbinafine (Lamisil) Product Portfolios and Specifications
13.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 TEVA Main Business Overview
13.4.5 TEVA Latest Developments
13.5 Mylan Pharmaceuticals
13.5.1 Mylan Pharmaceuticals Company Information
13.5.2 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Pharmaceuticals Main Business Overview
13.5.5 Mylan Pharmaceuticals Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Terbinafine (Lamisil) Product Portfolios and Specifications
13.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sivem Pharmaceuticals
13.7.1 Sivem Pharmaceuticals Company Information
13.7.2 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sivem Pharmaceuticals Main Business Overview
13.7.5 Sivem Pharmaceuticals Latest Developments
13.8 Apotex Corporation
13.8.1 Apotex Corporation Company Information
13.8.2 Apotex Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
13.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Apotex Corporation Main Business Overview
13.8.5 Apotex Corporation Latest Developments
13.9 Auro Pharma Inc
13.9.1 Auro Pharma Inc Company Information
13.9.2 Auro Pharma Inc Terbinafine (Lamisil) Product Portfolios and Specifications
13.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Auro Pharma Inc Main Business Overview
13.9.5 Auro Pharma Inc Latest Developments
13.10 PLIVA
13.10.1 PLIVA Company Information
13.10.2 PLIVA Terbinafine (Lamisil) Product Portfolios and Specifications
13.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 PLIVA Main Business Overview
13.10.5 PLIVA Latest Developments
13.11 Jamp Pharma Corporation
13.11.1 Jamp Pharma Corporation Company Information
13.11.2 Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
13.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jamp Pharma Corporation Main Business Overview
13.11.5 Jamp Pharma Corporation Latest Developments
13.12 Nu Pharm
13.12.1 Nu Pharm Company Information
13.12.2 Nu Pharm Terbinafine (Lamisil) Product Portfolios and Specifications
13.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nu Pharm Main Business Overview
13.12.5 Nu Pharm Latest Developments
13.13 Codal Synto
13.13.1 Codal Synto Company Information
13.13.2 Codal Synto Terbinafine (Lamisil) Product Portfolios and Specifications
13.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Codal Synto Main Business Overview
13.13.5 Codal Synto Latest Developments
13.14 Qd Pharmaceuticals
13.14.1 Qd Pharmaceuticals Company Information
13.14.2 Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Qd Pharmaceuticals Main Business Overview
13.14.5 Qd Pharmaceuticals Latest Developments
13.15 Pharmel Inc
13.15.1 Pharmel Inc Company Information
13.15.2 Pharmel Inc Terbinafine (Lamisil) Product Portfolios and Specifications
13.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Pharmel Inc Main Business Overview
13.15.5 Pharmel Inc Latest Developments
13.16 Smaart Pharmaceutticals
13.16.1 Smaart Pharmaceutticals Company Information
13.16.2 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Smaart Pharmaceutticals Main Business Overview
13.16.5 Smaart Pharmaceutticals Latest Developments
13.17 Qilu Pharmaceutical
13.17.1 Qilu Pharmaceutical Company Information
13.17.2 Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
13.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Qilu Pharmaceutical Main Business Overview
13.17.5 Qilu Pharmaceutical Latest Developments
13.18 Qingdao Jinfeng Pharmaceutical
13.18.1 Qingdao Jinfeng Pharmaceutical Company Information
13.18.2 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
13.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Qingdao Jinfeng Pharmaceutical Main Business Overview
13.18.5 Qingdao Jinfeng Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Terbinafine (Lamisil) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Terbinafine (Lamisil) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Terbinafine (Lamisil) by Country/Region, 2018, 2022 & 2029
2.2 Terbinafine (Lamisil) Segment by Type
2.2.1 Oral
2.2.2 External Use
2.3 Terbinafine (Lamisil) Sales by Type
2.3.1 Global Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
2.3.2 Global Terbinafine (Lamisil) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Terbinafine (Lamisil) Sale Price by Type (2018-2023)
2.4 Terbinafine (Lamisil) Segment by Application
2.4.1 Fungal Infection Of The Skin And Mucous Membrane
2.4.2 Onychomycosis
2.4.3 Bronchial Asthma
2.4.4 Gynecological Anti-Infection Preparation
2.4.5 Other
2.5 Terbinafine (Lamisil) Sales by Application
2.5.1 Global Terbinafine (Lamisil) Sale Market Share by Application (2018-2023)
2.5.2 Global Terbinafine (Lamisil) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Terbinafine (Lamisil) Sale Price by Application (2018-2023)
3 GLOBAL TERBINAFINE (LAMISIL) BY COMPANY
3.1 Global Terbinafine (Lamisil) Breakdown Data by Company
3.1.1 Global Terbinafine (Lamisil) Annual Sales by Company (2018-2023)
3.1.2 Global Terbinafine (Lamisil) Sales Market Share by Company (2018-2023)
3.2 Global Terbinafine (Lamisil) Annual Revenue by Company (2018-2023)
3.2.1 Global Terbinafine (Lamisil) Revenue by Company (2018-2023)
3.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Company (2018-2023)
3.3 Global Terbinafine (Lamisil) Sale Price by Company
3.4 Key Manufacturers Terbinafine (Lamisil) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Terbinafine (Lamisil) Product Location Distribution
3.4.2 Players Terbinafine (Lamisil) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TERBINAFINE (LAMISIL) BY GEOGRAPHIC REGION
4.1 World Historic Terbinafine (Lamisil) Market Size by Geographic Region (2018-2023)
4.1.1 Global Terbinafine (Lamisil) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Terbinafine (Lamisil) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Terbinafine (Lamisil) Market Size by Country/Region (2018-2023)
4.2.1 Global Terbinafine (Lamisil) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Terbinafine (Lamisil) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Terbinafine (Lamisil) Sales Growth
4.4 APAC Terbinafine (Lamisil) Sales Growth
4.5 Europe Terbinafine (Lamisil) Sales Growth
4.6 Middle East & Africa Terbinafine (Lamisil) Sales Growth
5 AMERICAS
5.1 Americas Terbinafine (Lamisil) Sales by Country
5.1.1 Americas Terbinafine (Lamisil) Sales by Country (2018-2023)
5.1.2 Americas Terbinafine (Lamisil) Revenue by Country (2018-2023)
5.2 Americas Terbinafine (Lamisil) Sales by Type
5.3 Americas Terbinafine (Lamisil) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Terbinafine (Lamisil) Sales by Region
6.1.1 APAC Terbinafine (Lamisil) Sales by Region (2018-2023)
6.1.2 APAC Terbinafine (Lamisil) Revenue by Region (2018-2023)
6.2 APAC Terbinafine (Lamisil) Sales by Type
6.3 APAC Terbinafine (Lamisil) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Terbinafine (Lamisil) by Country
7.1.1 Europe Terbinafine (Lamisil) Sales by Country (2018-2023)
7.1.2 Europe Terbinafine (Lamisil) Revenue by Country (2018-2023)
7.2 Europe Terbinafine (Lamisil) Sales by Type
7.3 Europe Terbinafine (Lamisil) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Terbinafine (Lamisil) by Country
8.1.1 Middle East & Africa Terbinafine (Lamisil) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2018-2023)
8.2 Middle East & Africa Terbinafine (Lamisil) Sales by Type
8.3 Middle East & Africa Terbinafine (Lamisil) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Terbinafine (Lamisil)
10.3 Manufacturing Process Analysis of Terbinafine (Lamisil)
10.4 Industry Chain Structure of Terbinafine (Lamisil)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Terbinafine (Lamisil) Distributors
11.3 Terbinafine (Lamisil) Customer
12 WORLD FORECAST REVIEW FOR TERBINAFINE (LAMISIL) BY GEOGRAPHIC REGION
12.1 Global Terbinafine (Lamisil) Market Size Forecast by Region
12.1.1 Global Terbinafine (Lamisil) Forecast by Region (2024-2029)
12.1.2 Global Terbinafine (Lamisil) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Terbinafine (Lamisil) Forecast by Type
12.7 Global Terbinafine (Lamisil) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Perrigo
13.1.1 Perrigo Company Information
13.1.2 Perrigo Terbinafine (Lamisil) Product Portfolios and Specifications
13.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Perrigo Main Business Overview
13.1.5 Perrigo Latest Developments
13.2 Novartis Pharmaceuticals Corporation
13.2.1 Novartis Pharmaceuticals Corporation Company Information
13.2.2 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
13.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Pharmaceuticals Corporation Main Business Overview
13.2.5 Novartis Pharmaceuticals Corporation Latest Developments
13.3 Gokul Pharma
13.3.1 Gokul Pharma Company Information
13.3.2 Gokul Pharma Terbinafine (Lamisil) Product Portfolios and Specifications
13.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Gokul Pharma Main Business Overview
13.3.5 Gokul Pharma Latest Developments
13.4 TEVA
13.4.1 TEVA Company Information
13.4.2 TEVA Terbinafine (Lamisil) Product Portfolios and Specifications
13.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 TEVA Main Business Overview
13.4.5 TEVA Latest Developments
13.5 Mylan Pharmaceuticals
13.5.1 Mylan Pharmaceuticals Company Information
13.5.2 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Pharmaceuticals Main Business Overview
13.5.5 Mylan Pharmaceuticals Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Terbinafine (Lamisil) Product Portfolios and Specifications
13.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sivem Pharmaceuticals
13.7.1 Sivem Pharmaceuticals Company Information
13.7.2 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sivem Pharmaceuticals Main Business Overview
13.7.5 Sivem Pharmaceuticals Latest Developments
13.8 Apotex Corporation
13.8.1 Apotex Corporation Company Information
13.8.2 Apotex Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
13.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Apotex Corporation Main Business Overview
13.8.5 Apotex Corporation Latest Developments
13.9 Auro Pharma Inc
13.9.1 Auro Pharma Inc Company Information
13.9.2 Auro Pharma Inc Terbinafine (Lamisil) Product Portfolios and Specifications
13.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Auro Pharma Inc Main Business Overview
13.9.5 Auro Pharma Inc Latest Developments
13.10 PLIVA
13.10.1 PLIVA Company Information
13.10.2 PLIVA Terbinafine (Lamisil) Product Portfolios and Specifications
13.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 PLIVA Main Business Overview
13.10.5 PLIVA Latest Developments
13.11 Jamp Pharma Corporation
13.11.1 Jamp Pharma Corporation Company Information
13.11.2 Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
13.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jamp Pharma Corporation Main Business Overview
13.11.5 Jamp Pharma Corporation Latest Developments
13.12 Nu Pharm
13.12.1 Nu Pharm Company Information
13.12.2 Nu Pharm Terbinafine (Lamisil) Product Portfolios and Specifications
13.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nu Pharm Main Business Overview
13.12.5 Nu Pharm Latest Developments
13.13 Codal Synto
13.13.1 Codal Synto Company Information
13.13.2 Codal Synto Terbinafine (Lamisil) Product Portfolios and Specifications
13.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Codal Synto Main Business Overview
13.13.5 Codal Synto Latest Developments
13.14 Qd Pharmaceuticals
13.14.1 Qd Pharmaceuticals Company Information
13.14.2 Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Qd Pharmaceuticals Main Business Overview
13.14.5 Qd Pharmaceuticals Latest Developments
13.15 Pharmel Inc
13.15.1 Pharmel Inc Company Information
13.15.2 Pharmel Inc Terbinafine (Lamisil) Product Portfolios and Specifications
13.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Pharmel Inc Main Business Overview
13.15.5 Pharmel Inc Latest Developments
13.16 Smaart Pharmaceutticals
13.16.1 Smaart Pharmaceutticals Company Information
13.16.2 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolios and Specifications
13.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Smaart Pharmaceutticals Main Business Overview
13.16.5 Smaart Pharmaceutticals Latest Developments
13.17 Qilu Pharmaceutical
13.17.1 Qilu Pharmaceutical Company Information
13.17.2 Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
13.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Qilu Pharmaceutical Main Business Overview
13.17.5 Qilu Pharmaceutical Latest Developments
13.18 Qingdao Jinfeng Pharmaceutical
13.18.1 Qingdao Jinfeng Pharmaceutical Company Information
13.18.2 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
13.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Qingdao Jinfeng Pharmaceutical Main Business Overview
13.18.5 Qingdao Jinfeng Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Terbinafine (Lamisil) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Terbinafine (Lamisil) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of External Use
Table 5. Global Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 6. Global Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Table 7. Global Terbinafine (Lamisil) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Terbinafine (Lamisil) Revenue Market Share by Type (2018-2023)
Table 9. Global Terbinafine (Lamisil) Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 11. Global Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Table 12. Global Terbinafine (Lamisil) Revenue by Application (2018-2023)
Table 13. Global Terbinafine (Lamisil) Revenue Market Share by Application (2018-2023)
Table 14. Global Terbinafine (Lamisil) Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Terbinafine (Lamisil) Sales by Company (2018-2023) & (KG)
Table 16. Global Terbinafine (Lamisil) Sales Market Share by Company (2018-2023)
Table 17. Global Terbinafine (Lamisil) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Terbinafine (Lamisil) Revenue Market Share by Company (2018-2023)
Table 19. Global Terbinafine (Lamisil) Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Terbinafine (Lamisil) Producing Area Distribution and Sales Area
Table 21. Players Terbinafine (Lamisil) Products Offered
Table 22. Terbinafine (Lamisil) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Terbinafine (Lamisil) Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Terbinafine (Lamisil) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Terbinafine (Lamisil) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Terbinafine (Lamisil) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Terbinafine (Lamisil) Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Terbinafine (Lamisil) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Terbinafine (Lamisil) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Terbinafine (Lamisil) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Terbinafine (Lamisil) Sales by Country (2018-2023) & (KG)
Table 34. Americas Terbinafine (Lamisil) Sales Market Share by Country (2018-2023)
Table 35. Americas Terbinafine (Lamisil) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Terbinafine (Lamisil) Revenue Market Share by Country (2018-2023)
Table 37. Americas Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 38. Americas Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 39. APAC Terbinafine (Lamisil) Sales by Region (2018-2023) & (KG)
Table 40. APAC Terbinafine (Lamisil) Sales Market Share by Region (2018-2023)
Table 41. APAC Terbinafine (Lamisil) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Terbinafine (Lamisil) Revenue Market Share by Region (2018-2023)
Table 43. APAC Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 44. APAC Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 45. Europe Terbinafine (Lamisil) Sales by Country (2018-2023) & (KG)
Table 46. Europe Terbinafine (Lamisil) Sales Market Share by Country (2018-2023)
Table 47. Europe Terbinafine (Lamisil) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2018-2023)
Table 49. Europe Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 50. Europe Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Terbinafine (Lamisil)
Table 58. Key Market Challenges & Risks of Terbinafine (Lamisil)
Table 59. Key Industry Trends of Terbinafine (Lamisil)
Table 60. Terbinafine (Lamisil) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Terbinafine (Lamisil) Distributors List
Table 63. Terbinafine (Lamisil) Customer List
Table 64. Global Terbinafine (Lamisil) Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Terbinafine (Lamisil) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Terbinafine (Lamisil) Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Terbinafine (Lamisil) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Terbinafine (Lamisil) Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Terbinafine (Lamisil) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Terbinafine (Lamisil) Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Terbinafine (Lamisil) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Terbinafine (Lamisil) Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Terbinafine (Lamisil) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Terbinafine (Lamisil) Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Terbinafine (Lamisil) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Terbinafine (Lamisil) Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Terbinafine (Lamisil) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Perrigo Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 79. Perrigo Terbinafine (Lamisil) Product Portfolios and Specifications
Table 80. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Perrigo Main Business
Table 82. Perrigo Latest Developments
Table 83. Novartis Pharmaceuticals Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
Table 85. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Novartis Pharmaceuticals Corporation Main Business
Table 87. Novartis Pharmaceuticals Corporation Latest Developments
Table 88. Gokul Pharma Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 89. Gokul Pharma Terbinafine (Lamisil) Product Portfolios and Specifications
Table 90. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. Gokul Pharma Main Business
Table 92. Gokul Pharma Latest Developments
Table 93. TEVA Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 94. TEVA Terbinafine (Lamisil) Product Portfolios and Specifications
Table 95. TEVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. TEVA Main Business
Table 97. TEVA Latest Developments
Table 98. Mylan Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 100. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. Mylan Pharmaceuticals Main Business
Table 102. Mylan Pharmaceuticals Latest Developments
Table 103. Pfizer Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Terbinafine (Lamisil) Product Portfolios and Specifications
Table 105. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sivem Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 109. Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 110. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Sivem Pharmaceuticals Main Business
Table 112. Sivem Pharmaceuticals Latest Developments
Table 113. Apotex Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 114. Apotex Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
Table 115. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Apotex Corporation Main Business
Table 117. Apotex Corporation Latest Developments
Table 118. Auro Pharma Inc Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 119. Auro Pharma Inc Terbinafine (Lamisil) Product Portfolios and Specifications
Table 120. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Auro Pharma Inc Main Business
Table 122. Auro Pharma Inc Latest Developments
Table 123. PLIVA Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 124. PLIVA Terbinafine (Lamisil) Product Portfolios and Specifications
Table 125. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. PLIVA Main Business
Table 127. PLIVA Latest Developments
Table 128. Jamp Pharma Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 129. Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
Table 130. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. Jamp Pharma Corporation Main Business
Table 132. Jamp Pharma Corporation Latest Developments
Table 133. Nu Pharm Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 134. Nu Pharm Terbinafine (Lamisil) Product Portfolios and Specifications
Table 135. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Nu Pharm Main Business
Table 137. Nu Pharm Latest Developments
Table 138. Codal Synto Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 139. Codal Synto Terbinafine (Lamisil) Product Portfolios and Specifications
Table 140. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Codal Synto Main Business
Table 142. Codal Synto Latest Developments
Table 143. Qd Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 144. Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 145. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 146. Qd Pharmaceuticals Main Business
Table 147. Qd Pharmaceuticals Latest Developments
Table 148. Pharmel Inc Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 149. Pharmel Inc Terbinafine (Lamisil) Product Portfolios and Specifications
Table 150. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 151. Pharmel Inc Main Business
Table 152. Pharmel Inc Latest Developments
Table 153. Smaart Pharmaceutticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 154. Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 155. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 156. Smaart Pharmaceutticals Main Business
Table 157. Smaart Pharmaceutticals Latest Developments
Table 158. Qilu Pharmaceutical Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 159. Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
Table 160. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 161. Qilu Pharmaceutical Main Business
Table 162. Qilu Pharmaceutical Latest Developments
Table 163. Qingdao Jinfeng Pharmaceutical Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 164. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
Table 165. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 166. Qingdao Jinfeng Pharmaceutical Main Business
Table 167. Qingdao Jinfeng Pharmaceutical Latest Developments
Table 1. Terbinafine (Lamisil) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Terbinafine (Lamisil) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of External Use
Table 5. Global Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 6. Global Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Table 7. Global Terbinafine (Lamisil) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Terbinafine (Lamisil) Revenue Market Share by Type (2018-2023)
Table 9. Global Terbinafine (Lamisil) Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 11. Global Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Table 12. Global Terbinafine (Lamisil) Revenue by Application (2018-2023)
Table 13. Global Terbinafine (Lamisil) Revenue Market Share by Application (2018-2023)
Table 14. Global Terbinafine (Lamisil) Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Terbinafine (Lamisil) Sales by Company (2018-2023) & (KG)
Table 16. Global Terbinafine (Lamisil) Sales Market Share by Company (2018-2023)
Table 17. Global Terbinafine (Lamisil) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Terbinafine (Lamisil) Revenue Market Share by Company (2018-2023)
Table 19. Global Terbinafine (Lamisil) Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Terbinafine (Lamisil) Producing Area Distribution and Sales Area
Table 21. Players Terbinafine (Lamisil) Products Offered
Table 22. Terbinafine (Lamisil) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Terbinafine (Lamisil) Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Terbinafine (Lamisil) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Terbinafine (Lamisil) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Terbinafine (Lamisil) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Terbinafine (Lamisil) Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Terbinafine (Lamisil) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Terbinafine (Lamisil) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Terbinafine (Lamisil) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Terbinafine (Lamisil) Sales by Country (2018-2023) & (KG)
Table 34. Americas Terbinafine (Lamisil) Sales Market Share by Country (2018-2023)
Table 35. Americas Terbinafine (Lamisil) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Terbinafine (Lamisil) Revenue Market Share by Country (2018-2023)
Table 37. Americas Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 38. Americas Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 39. APAC Terbinafine (Lamisil) Sales by Region (2018-2023) & (KG)
Table 40. APAC Terbinafine (Lamisil) Sales Market Share by Region (2018-2023)
Table 41. APAC Terbinafine (Lamisil) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Terbinafine (Lamisil) Revenue Market Share by Region (2018-2023)
Table 43. APAC Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 44. APAC Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 45. Europe Terbinafine (Lamisil) Sales by Country (2018-2023) & (KG)
Table 46. Europe Terbinafine (Lamisil) Sales Market Share by Country (2018-2023)
Table 47. Europe Terbinafine (Lamisil) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2018-2023)
Table 49. Europe Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 50. Europe Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Terbinafine (Lamisil) Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Terbinafine (Lamisil) Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Terbinafine (Lamisil)
Table 58. Key Market Challenges & Risks of Terbinafine (Lamisil)
Table 59. Key Industry Trends of Terbinafine (Lamisil)
Table 60. Terbinafine (Lamisil) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Terbinafine (Lamisil) Distributors List
Table 63. Terbinafine (Lamisil) Customer List
Table 64. Global Terbinafine (Lamisil) Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Terbinafine (Lamisil) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Terbinafine (Lamisil) Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Terbinafine (Lamisil) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Terbinafine (Lamisil) Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Terbinafine (Lamisil) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Terbinafine (Lamisil) Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Terbinafine (Lamisil) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Terbinafine (Lamisil) Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Terbinafine (Lamisil) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Terbinafine (Lamisil) Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Terbinafine (Lamisil) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Terbinafine (Lamisil) Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Terbinafine (Lamisil) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Perrigo Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 79. Perrigo Terbinafine (Lamisil) Product Portfolios and Specifications
Table 80. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Perrigo Main Business
Table 82. Perrigo Latest Developments
Table 83. Novartis Pharmaceuticals Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
Table 85. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Novartis Pharmaceuticals Corporation Main Business
Table 87. Novartis Pharmaceuticals Corporation Latest Developments
Table 88. Gokul Pharma Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 89. Gokul Pharma Terbinafine (Lamisil) Product Portfolios and Specifications
Table 90. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. Gokul Pharma Main Business
Table 92. Gokul Pharma Latest Developments
Table 93. TEVA Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 94. TEVA Terbinafine (Lamisil) Product Portfolios and Specifications
Table 95. TEVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. TEVA Main Business
Table 97. TEVA Latest Developments
Table 98. Mylan Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 100. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. Mylan Pharmaceuticals Main Business
Table 102. Mylan Pharmaceuticals Latest Developments
Table 103. Pfizer Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Terbinafine (Lamisil) Product Portfolios and Specifications
Table 105. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sivem Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 109. Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 110. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Sivem Pharmaceuticals Main Business
Table 112. Sivem Pharmaceuticals Latest Developments
Table 113. Apotex Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 114. Apotex Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
Table 115. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Apotex Corporation Main Business
Table 117. Apotex Corporation Latest Developments
Table 118. Auro Pharma Inc Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 119. Auro Pharma Inc Terbinafine (Lamisil) Product Portfolios and Specifications
Table 120. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Auro Pharma Inc Main Business
Table 122. Auro Pharma Inc Latest Developments
Table 123. PLIVA Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 124. PLIVA Terbinafine (Lamisil) Product Portfolios and Specifications
Table 125. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. PLIVA Main Business
Table 127. PLIVA Latest Developments
Table 128. Jamp Pharma Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 129. Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolios and Specifications
Table 130. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. Jamp Pharma Corporation Main Business
Table 132. Jamp Pharma Corporation Latest Developments
Table 133. Nu Pharm Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 134. Nu Pharm Terbinafine (Lamisil) Product Portfolios and Specifications
Table 135. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Nu Pharm Main Business
Table 137. Nu Pharm Latest Developments
Table 138. Codal Synto Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 139. Codal Synto Terbinafine (Lamisil) Product Portfolios and Specifications
Table 140. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Codal Synto Main Business
Table 142. Codal Synto Latest Developments
Table 143. Qd Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 144. Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 145. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 146. Qd Pharmaceuticals Main Business
Table 147. Qd Pharmaceuticals Latest Developments
Table 148. Pharmel Inc Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 149. Pharmel Inc Terbinafine (Lamisil) Product Portfolios and Specifications
Table 150. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 151. Pharmel Inc Main Business
Table 152. Pharmel Inc Latest Developments
Table 153. Smaart Pharmaceutticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 154. Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolios and Specifications
Table 155. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 156. Smaart Pharmaceutticals Main Business
Table 157. Smaart Pharmaceutticals Latest Developments
Table 158. Qilu Pharmaceutical Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 159. Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
Table 160. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 161. Qilu Pharmaceutical Main Business
Table 162. Qilu Pharmaceutical Latest Developments
Table 163. Qingdao Jinfeng Pharmaceutical Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 164. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolios and Specifications
Table 165. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 166. Qingdao Jinfeng Pharmaceutical Main Business
Table 167. Qingdao Jinfeng Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Terbinafine (Lamisil)
Figure 2. Terbinafine (Lamisil) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Terbinafine (Lamisil) Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Terbinafine (Lamisil) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Terbinafine (Lamisil) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of External Use
Figure 11. Global Terbinafine (Lamisil) Sales Market Share by Type in 2022
Figure 12. Global Terbinafine (Lamisil) Revenue Market Share by Type (2018-2023)
Figure 13. Terbinafine (Lamisil) Consumed in Fungal Infection Of The Skin And Mucous Membrane
Figure 14. Global Terbinafine (Lamisil) Market: Fungal Infection Of The Skin And Mucous Membrane (2018-2023) & (KG)
Figure 15. Terbinafine (Lamisil) Consumed in Onychomycosis
Figure 16. Global Terbinafine (Lamisil) Market: Onychomycosis (2018-2023) & (KG)
Figure 17. Terbinafine (Lamisil) Consumed in Bronchial Asthma
Figure 18. Global Terbinafine (Lamisil) Market: Bronchial Asthma (2018-2023) & (KG)
Figure 19. Terbinafine (Lamisil) Consumed in Gynecological Anti-Infection Preparation
Figure 20. Global Terbinafine (Lamisil) Market: Gynecological Anti-Infection Preparation (2018-2023) & (KG)
Figure 21. Terbinafine (Lamisil) Consumed in Other
Figure 22. Global Terbinafine (Lamisil) Market: Other (2018-2023) & (KG)
Figure 23. Global Terbinafine (Lamisil) Sales Market Share by Application (2022)
Figure 24. Global Terbinafine (Lamisil) Revenue Market Share by Application in 2022
Figure 25. Terbinafine (Lamisil) Sales Market by Company in 2022 (KG)
Figure 26. Global Terbinafine (Lamisil) Sales Market Share by Company in 2022
Figure 27. Terbinafine (Lamisil) Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Terbinafine (Lamisil) Revenue Market Share by Company in 2022
Figure 29. Global Terbinafine (Lamisil) Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Terbinafine (Lamisil) Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 32. Americas Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 33. APAC Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 34. APAC Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 35. Europe Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 36. Europe Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 38. Middle East & Africa Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 39. Americas Terbinafine (Lamisil) Sales Market Share by Country in 2022
Figure 40. Americas Terbinafine (Lamisil) Revenue Market Share by Country in 2022
Figure 41. Americas Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 42. Americas Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 43. United States Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Terbinafine (Lamisil) Sales Market Share by Region in 2022
Figure 48. APAC Terbinafine (Lamisil) Revenue Market Share by Regions in 2022
Figure 49. APAC Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 50. APAC Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 51. China Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Terbinafine (Lamisil) Sales Market Share by Country in 2022
Figure 59. Europe Terbinafine (Lamisil) Revenue Market Share by Country in 2022
Figure 60. Europe Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 61. Europe Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 62. Germany Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 71. Egypt Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Terbinafine (Lamisil) in 2022
Figure 77. Manufacturing Process Analysis of Terbinafine (Lamisil)
Figure 78. Industry Chain Structure of Terbinafine (Lamisil)
Figure 79. Channels of Distribution
Figure 80. Global Terbinafine (Lamisil) Sales Market Forecast by Region (2024-2029)
Figure 81. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Terbinafine (Lamisil) Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Terbinafine (Lamisil) Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Terbinafine (Lamisil)
Figure 2. Terbinafine (Lamisil) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Terbinafine (Lamisil) Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Terbinafine (Lamisil) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Terbinafine (Lamisil) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of External Use
Figure 11. Global Terbinafine (Lamisil) Sales Market Share by Type in 2022
Figure 12. Global Terbinafine (Lamisil) Revenue Market Share by Type (2018-2023)
Figure 13. Terbinafine (Lamisil) Consumed in Fungal Infection Of The Skin And Mucous Membrane
Figure 14. Global Terbinafine (Lamisil) Market: Fungal Infection Of The Skin And Mucous Membrane (2018-2023) & (KG)
Figure 15. Terbinafine (Lamisil) Consumed in Onychomycosis
Figure 16. Global Terbinafine (Lamisil) Market: Onychomycosis (2018-2023) & (KG)
Figure 17. Terbinafine (Lamisil) Consumed in Bronchial Asthma
Figure 18. Global Terbinafine (Lamisil) Market: Bronchial Asthma (2018-2023) & (KG)
Figure 19. Terbinafine (Lamisil) Consumed in Gynecological Anti-Infection Preparation
Figure 20. Global Terbinafine (Lamisil) Market: Gynecological Anti-Infection Preparation (2018-2023) & (KG)
Figure 21. Terbinafine (Lamisil) Consumed in Other
Figure 22. Global Terbinafine (Lamisil) Market: Other (2018-2023) & (KG)
Figure 23. Global Terbinafine (Lamisil) Sales Market Share by Application (2022)
Figure 24. Global Terbinafine (Lamisil) Revenue Market Share by Application in 2022
Figure 25. Terbinafine (Lamisil) Sales Market by Company in 2022 (KG)
Figure 26. Global Terbinafine (Lamisil) Sales Market Share by Company in 2022
Figure 27. Terbinafine (Lamisil) Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Terbinafine (Lamisil) Revenue Market Share by Company in 2022
Figure 29. Global Terbinafine (Lamisil) Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Terbinafine (Lamisil) Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 32. Americas Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 33. APAC Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 34. APAC Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 35. Europe Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 36. Europe Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Terbinafine (Lamisil) Sales 2018-2023 (KG)
Figure 38. Middle East & Africa Terbinafine (Lamisil) Revenue 2018-2023 ($ Millions)
Figure 39. Americas Terbinafine (Lamisil) Sales Market Share by Country in 2022
Figure 40. Americas Terbinafine (Lamisil) Revenue Market Share by Country in 2022
Figure 41. Americas Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 42. Americas Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 43. United States Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Terbinafine (Lamisil) Sales Market Share by Region in 2022
Figure 48. APAC Terbinafine (Lamisil) Revenue Market Share by Regions in 2022
Figure 49. APAC Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 50. APAC Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 51. China Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Terbinafine (Lamisil) Sales Market Share by Country in 2022
Figure 59. Europe Terbinafine (Lamisil) Revenue Market Share by Country in 2022
Figure 60. Europe Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 61. Europe Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 62. Germany Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Application (2018-2023)
Figure 71. Egypt Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Terbinafine (Lamisil) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Terbinafine (Lamisil) in 2022
Figure 77. Manufacturing Process Analysis of Terbinafine (Lamisil)
Figure 78. Industry Chain Structure of Terbinafine (Lamisil)
Figure 79. Channels of Distribution
Figure 80. Global Terbinafine (Lamisil) Sales Market Forecast by Region (2024-2029)
Figure 81. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Terbinafine (Lamisil) Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Terbinafine (Lamisil) Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Application (2024-2029)
